EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark A2 BIOTHERAPEUTICS was filed as Word mark on 08/13/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/09/2020.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018107040 |
| Application date | August 13, 2019 |
| Publication date | September 19, 2019 |
| Entry date | January 9, 2020 |
| Expiration date | August 13, 2029 |
Trademark owner
30301 Agoura Road, Suite 210
91301 Agoura Hills
US
91301 Agoura Hills
US
Trademark representatives
Avenue Louise 235
1050 Bruxelles
BE
goods and services
5
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products for the treatment of cancer, inflammation and inflammatory diseases; T-cell pharmaceutical products for the treatment of cancer and inflammatory diseases; therapeutic targets for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutics and cellular therapies for the treatment of cancer, inflammation, and inflammatory diseases; biologics for in-vitro diagnostic use
42
Provision of, and identification and development of, therapeutic targets for others for the treatment and prevention of cancer, inflammation and inflammatory diseases; development of therapeutics and cellular therapies for treatment of cancer, inflammation, and inflammatory diseases; biotechnology research, development, testing and analysis for the treatment of cancer, inflammation, and inflammatory diseases; scientific research and development services; providing information relating to treatment and prevention of cancer, inflammation and inflammatory diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| March 18, 2020 | Change Representative, Published |
ID: 11018107040